COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 2549: Articles 25481-25490  | Next

Introduction to and spread of COVID-19 in care homes in Norfolk, UK
Brainard, J. S., Rushton, S., Winters, T., Hunter, P. R.
10.1101/2020.06.17.20133629 — Posted: 2020-06-18
GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia
Corral, L., Bahamonde, A., Arnaiz delas Revillas, F., Gomez-Barquero, J., Abadia-Otero, J., Garcia-Ibarbia, C., Mora, V., cerezo-hernandez, A., Hernandez, J. L., Lopez-Muniz, G., Hernandez-Blanco, F., Cifrian, J. M., Olmos, J. M., Carrascosa, M., farinas, m. C., Riancho, J. A., Glucocovid investigators
10.1101/2020.06.17.20133579 — Posted: 2020-06-18 Discussion: Onsite
Mathematical Modeling of Coronavirus Reproduction Rate with Policy and Behavioral Effects
Anzum, R., Islam, M. Z.
10.1101/2020.06.16.20133330 — Posted: 2020-06-18
The effectiveness of interventions to reduce COVID-19 transmission in a large urban jail
Malloy, G. S. P., Puglisi, L., Brandeau, M. L., Harvey, T. D., Wang, E. A.
10.1101/2020.06.16.20133280 — Posted: 2020-06-18
Rapid assessment of ligand binding to the SARS-CoV-2 main protease by saturation transfer difference NMR spectroscopy
Kantsadi, A. L., Vakonakis, I.
10.1101/2020.06.17.156679 — Posted: 2020-06-17
Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV
Stukalov, A., Girault, V., Grass, V., Bergant, V., Karayel, O., Urban, C., Haas, D. A., Huang, Y., Oubraham, L., Wang, A., Hamad, S. M., Piras, A., Tanzer, M., Hansen, F. M., Engleitner, T., Reinecke, M., Lavacca, T. M., Ehmann, R., Wölfel, R., Jores, J., Küster, B., Protzer, U., Rad, R., Ziebuhr, J., Thiel, V., Scaturro, P., Mann, M., Pichlmair, A.
10.1101/2020.06.17.156455 — Posted: 2020-06-17 Discussion: Onsite
Pervasive RNA secondary structure in the genomes of SARS-CoV-2 and other coronaviruses - an endeavour to understand its biological purpose
Simmonds, P.
10.1101/2020.06.17.155200 — Posted: 2020-06-17 Discussion: Onsite
High-Accuracy Multiplexed SARS-CoV-2 Antibody Assay with Avidity and Saliva Capability on a Nano-Plasmonic Platform
Liu, T., Hsiung, J., Zhao, S., Kost, J., Sreedhar, D., Olson, K., Keare, D., Roche, J., Hanson, C. V., Press, C., Boggs, J., Rodriguez-Soto, J. P., Montoya, J. G., Tang, M., Dai, H.
10.1101/2020.06.16.155580 — Posted: 2020-06-17
Holder Pasteurization Inactivates SARS-CoV-2 in Human Breast Milk
Conzelmann, C., Gross, R., Meister, T. L., Todt, D., Krawczyk, A., Dittmer, U., Stenger, S., Muench, J., Steinmann, E., Mueller, J. A., Pfaender, S.
10.1101/2020.06.17.155689 — Posted: 2020-06-17
Crystal structure of SARS-CoV-2 main protease in complex with a Chinese herb inhibitor shikonin
Li, J., Zhou, X., Zhang, Y., Zhong, F., Lin, C., McCormick, P. J., Jiang, F., Zhou, H., Wang, Q., Duan, J., Zhang, J.
10.1101/2020.06.16.155812 — Posted: 2020-06-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).